Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 32.42.
Forward PE Ratio (32.42) = Close Price ($353.24) / Consensus Forward EPS ($10.80)
FORWARD PE RATIO
32.42
SECTOR MEDIAN · HEALTHCARE
19.76
median of 78 covered companies
CURRENT VS SECTOR MEDIAN
+64.11%
vs the sector median at left
Intuitive Surgical, Inc.
Market Cap
$124.79B
Forward PE Ratio
32.42
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Intuitive Surgical, Inc. (ISRG) | $124.79B | 32.42 |
| CVS Health Corp. (CVS)vs › | $121.70B | 12.01 |
| Bristol-Myers Squibb Company (BMY)vs › | $131.57B | 9.34 |
| Medtronic plc (MDT)vs › | $117.62B | 16.74 |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $132.26B | 28.21 |
| Stryker Corporation (SYK)vs › | $105.57B | 18.41 |
| Danaher Corporation (DHR)vs › | $144.11B | 24.14 |
| McKesson Corporation (MCK)vs › | $104.40B | 22.79 |
| Sanofi (SNY)vs › | $102.89B | N/A |
| GSK plc (GSK)vs › | $97.43B | 13.54 |
Trailing P/E
39.8
reported TTM EPS
Forward P/E
32.4
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $10.80 implies +22.9% EPS growth vs the reported trailing $8.79.
At today's $353.24 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $10.80 | $10.49 – $10.95 | 16 | 32.7x |
| 2027-12-31 | $12.08 | $11.85 – $12.70 | 17 | 29.2x |
| 2028-12-31 | $13.60 | $12.07 – $15.07 | 8 | 26.0x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute